학술논문
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
Document Type
Article
Author
Diamond, Benjamin ; Korde, Neha; Lesokhin, Alexander M; Smith, Eric L; Shah, Urvi; Mailankody, Sham; Hultcrantz, Malin; Hassoun, Hani; Lu, Sydney X; Tan, Carlyn; Rustad, Even H; Maura, Francesco; Maclachlan, Kylee; Peterson, Tim; Derkach, Andriy; Devlin, Sean; Landau, Heather J; Scordo, Michael; Chung, David J; Shah, Gunjan L; Lahoud, Oscar; Thoren, Katie; Murata, Kazunori; Ramanathan, Lakshmi; Arcila, Maria E; Ho, Caleb; Roshal, Mikhail; Dogan, Ahmet; Giralt, Sergio A; Landgren, Ola
Source
In The Lancet Haematology June 2021 8(6):e422-e432
Subject
Language
ISSN
2352-3026